Copharos

Quick facts

Phase 1 pipeline

• 111In-DAC · Oncology
  A radiolabeled antibody-drug conjugate targeting CD19

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Copharos portfolio CI brief
• Copharos pipeline updates RSS